CN104357401B - 可分泌抗ii型登革病毒ns1单克隆抗体的杂交瘤细胞、单克隆抗体及应用 - Google Patents
可分泌抗ii型登革病毒ns1单克隆抗体的杂交瘤细胞、单克隆抗体及应用 Download PDFInfo
- Publication number
- CN104357401B CN104357401B CN201410606685.4A CN201410606685A CN104357401B CN 104357401 B CN104357401 B CN 104357401B CN 201410606685 A CN201410606685 A CN 201410606685A CN 104357401 B CN104357401 B CN 104357401B
- Authority
- CN
- China
- Prior art keywords
- dengue virus
- monoclonal antibody
- pad
- types
- detection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000725619 Dengue virus Species 0.000 title claims abstract description 82
- 210000004408 hybridoma Anatomy 0.000 title claims abstract description 25
- 238000012360 testing method Methods 0.000 claims abstract description 23
- 238000001514 detection method Methods 0.000 claims description 66
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 44
- 239000010931 gold Substances 0.000 claims description 19
- 229910052737 gold Inorganic materials 0.000 claims description 19
- 239000000020 Nitrocellulose Substances 0.000 claims description 18
- 229920001220 nitrocellulos Polymers 0.000 claims description 18
- 238000010521 absorption reaction Methods 0.000 claims description 17
- 239000000084 colloidal system Substances 0.000 claims description 15
- 241001494479 Pecora Species 0.000 claims description 7
- 230000028327 secretion Effects 0.000 claims description 5
- 239000003292 glue Substances 0.000 claims description 2
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 claims 5
- 239000000427 antigen Substances 0.000 abstract description 20
- 102000036639 antigens Human genes 0.000 abstract description 19
- 108091007433 antigens Proteins 0.000 abstract description 19
- 230000003248 secreting effect Effects 0.000 abstract description 8
- 230000035945 sensitivity Effects 0.000 abstract description 6
- 238000002372 labelling Methods 0.000 abstract description 4
- 239000002105 nanoparticle Substances 0.000 abstract description 3
- 230000009467 reduction Effects 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 description 29
- 210000004027 cell Anatomy 0.000 description 28
- 101710128560 Initiator protein NS1 Proteins 0.000 description 25
- 101710144127 Non-structural protein 1 Proteins 0.000 description 25
- 239000000243 solution Substances 0.000 description 25
- 206010012310 Dengue fever Diseases 0.000 description 20
- 239000007788 liquid Substances 0.000 description 20
- 208000025729 dengue disease Diseases 0.000 description 18
- 238000005406 washing Methods 0.000 description 17
- 208000001490 Dengue Diseases 0.000 description 14
- 206010003445 Ascites Diseases 0.000 description 13
- 239000006228 supernatant Substances 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 239000012980 RPMI-1640 medium Substances 0.000 description 11
- 239000003153 chemical reaction reagent Substances 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 11
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000008367 deionised water Substances 0.000 description 9
- 229910021641 deionized water Inorganic materials 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- 239000007853 buffer solution Substances 0.000 description 7
- 208000009714 Severe Dengue Diseases 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 230000004927 fusion Effects 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- 238000005374 membrane filtration Methods 0.000 description 6
- 230000009182 swimming Effects 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 238000011725 BALB/c mouse Methods 0.000 description 4
- 238000002965 ELISA Methods 0.000 description 4
- 206010035226 Plasma cell myeloma Diseases 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 201000002950 dengue hemorrhagic fever Diseases 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 201000000050 myeloid neoplasm Diseases 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- YNPNZTXNASCQKK-UHFFFAOYSA-N phenanthrene Chemical compound C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- 238000004321 preservation Methods 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 229920002538 Polyethylene Glycol 20000 Polymers 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 101710172711 Structural protein Proteins 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000007910 cell fusion Effects 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000005538 encapsulation Methods 0.000 description 3
- FDWREHZXQUYJFJ-UHFFFAOYSA-M gold monochloride Chemical compound [Cl-].[Au+] FDWREHZXQUYJFJ-UHFFFAOYSA-M 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 238000002649 immunization Methods 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 239000001509 sodium citrate Substances 0.000 description 3
- 210000004989 spleen cell Anatomy 0.000 description 3
- 238000008157 ELISA kit Methods 0.000 description 2
- 241000710831 Flavivirus Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 239000012807 PCR reagent Substances 0.000 description 2
- 206010068676 Pneumoretroperitoneum Diseases 0.000 description 2
- 208000005727 Retropneumoperitoneum Diseases 0.000 description 2
- 244000061458 Solanum melongena Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 201000009892 dengue shock syndrome Diseases 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000000644 propagated effect Effects 0.000 description 2
- 238000002731 protein assay Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 2
- 235000019263 trisodium citrate Nutrition 0.000 description 2
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- GHCZTIFQWKKGSB-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;phosphoric acid Chemical compound OP(O)(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O GHCZTIFQWKKGSB-UHFFFAOYSA-N 0.000 description 1
- 241000256118 Aedes aegypti Species 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 101710204837 Envelope small membrane protein Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 101710145006 Lysis protein Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241000187480 Mycobacterium smegmatis Species 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- SJUCACGNNJFHLB-UHFFFAOYSA-N O=C1N[ClH](=O)NC2=C1NC(=O)N2 Chemical compound O=C1N[ClH](=O)NC2=C1NC(=O)N2 SJUCACGNNJFHLB-UHFFFAOYSA-N 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 229920002535 Polyethylene Glycol 1500 Polymers 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 241000710914 Totivirus Species 0.000 description 1
- 108010087302 Viral Structural Proteins Proteins 0.000 description 1
- LUXUAZKGQZPOBZ-SAXJAHGMSA-N [(3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (Z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O LUXUAZKGQZPOBZ-SAXJAHGMSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 230000005875 antibody response Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- -1 collaurum Substances 0.000 description 1
- 238000012875 competitive assay Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000003636 conditioned culture medium Substances 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 229940023605 dengue virus vaccine Drugs 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- RJHLTVSLYWWTEF-UHFFFAOYSA-K gold trichloride Chemical class Cl[Au](Cl)Cl RJHLTVSLYWWTEF-UHFFFAOYSA-K 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 102000057593 human F8 Human genes 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 229940005654 nitrite ion Drugs 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 229940047431 recombinate Drugs 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410606685.4A CN104357401B (zh) | 2014-10-30 | 2014-10-30 | 可分泌抗ii型登革病毒ns1单克隆抗体的杂交瘤细胞、单克隆抗体及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410606685.4A CN104357401B (zh) | 2014-10-30 | 2014-10-30 | 可分泌抗ii型登革病毒ns1单克隆抗体的杂交瘤细胞、单克隆抗体及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104357401A CN104357401A (zh) | 2015-02-18 |
CN104357401B true CN104357401B (zh) | 2018-01-09 |
Family
ID=52524714
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410606685.4A Active CN104357401B (zh) | 2014-10-30 | 2014-10-30 | 可分泌抗ii型登革病毒ns1单克隆抗体的杂交瘤细胞、单克隆抗体及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104357401B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106290847A (zh) * | 2015-05-13 | 2017-01-04 | 上海凯创生物技术有限公司 | 一种登革热病毒ns1抗原乳胶法检测试剂盒 |
CN106309278B (zh) * | 2016-08-31 | 2020-05-08 | 澳宝化妆品(惠州)有限公司 | 用于抗衰老化妆品的龙舌兰发酵物及其制备方法和应用 |
CN106701812A (zh) * | 2016-12-27 | 2017-05-24 | 中国医学科学院医学生物学研究所 | 一种i‑iv型串联登革病毒edⅲ重组蛋白的构建方法及其应用 |
CN107177557B (zh) * | 2017-05-04 | 2019-12-27 | 菲鹏生物股份有限公司 | 可分泌抗h-fabp单克隆抗体的杂交瘤细胞、单克隆抗体及其制备方法和应用 |
CN109081869B (zh) * | 2018-08-28 | 2022-06-03 | 东莞市朋志生物科技有限公司 | Ns1蛋白的结合蛋白 |
CN110007095A (zh) * | 2019-05-06 | 2019-07-12 | 江苏硕世生物科技股份有限公司 | 一种登革病毒ns1抗原检测试纸条、试剂盒及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102161983A (zh) * | 2011-03-28 | 2011-08-24 | 中山大学 | Ⅰ-iv型登革病毒ns1单克隆抗体杂交瘤细胞株及其试剂盒 |
CN103396481A (zh) * | 2013-07-18 | 2013-11-20 | 华南理工大学 | 一种二型登革热病毒ns1蛋白的重链单域抗体及其制备方法和应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8920804B2 (en) * | 2011-12-22 | 2014-12-30 | Inbios International, Inc. | Methods and materials for the detection of dengue virus infection |
-
2014
- 2014-10-30 CN CN201410606685.4A patent/CN104357401B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102161983A (zh) * | 2011-03-28 | 2011-08-24 | 中山大学 | Ⅰ-iv型登革病毒ns1单克隆抗体杂交瘤细胞株及其试剂盒 |
CN103396481A (zh) * | 2013-07-18 | 2013-11-20 | 华南理工大学 | 一种二型登革热病毒ns1蛋白的重链单域抗体及其制备方法和应用 |
Non-Patent Citations (4)
Title |
---|
2型登革病毒NS1蛋白单克隆抗体的生物学特性研究;严炎炎等;《实用预防医学》;20081231;第15卷(第6期);第1943页 * |
Synergistic Interactins of Anti-NS1 Monoclonal Antibodies Protect Passively Immunized Mice from Lethal Challenge with Dengue 2 Virus;E.A.Henchal,et al;《Journal of General Virology》;19880801;全文 * |
抗2型登革病毒M蛋白和NS1蛋白单克隆抗体的制备及鉴定;但妍等;《中国优秀硕士论文全文数据库》;20090115;全文 * |
重组Ⅱ型登革病毒NS1的表达及其免疫原性的研究;李多等;《中国生物工程杂志》;20140808;第34卷(第9期);全文 * |
Also Published As
Publication number | Publication date |
---|---|
CN104357401A (zh) | 2015-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104357401B (zh) | 可分泌抗ii型登革病毒ns1单克隆抗体的杂交瘤细胞、单克隆抗体及应用 | |
CN102747040B (zh) | 一种抗甲型流感病毒核蛋白单克隆抗体及其制备与应用 | |
CN104450625B (zh) | 可分泌抗疟原虫乳酸脱氢酶单克隆抗体的杂交瘤细胞、单克隆抗体及应用 | |
CN103173420B (zh) | 可分泌抗心肌肌钙蛋白i单抗的杂交瘤细胞及应用 | |
CN105198990B (zh) | 用于Bt Cry1类毒素广谱检测的抗体及其制备方法与应用 | |
CN107022527A (zh) | 可分泌抗c反应蛋白单克隆抗体的杂交瘤细胞、c反应蛋白检测试剂及其制备方法和应用 | |
CN113637081A (zh) | 一株分泌抗二甲戊灵单克隆抗体的杂交瘤细胞株及其应用 | |
CN106636004A (zh) | 一种tmv‑cmv‑pvy三重病毒胶体金快速检测试纸条 | |
CN107012127B (zh) | 抗b型肝炎病毒核心抗原的单克隆抗体、其用途以及分泌所述单克隆抗体的杂交瘤细胞 | |
CN101551393B (zh) | 一种检测ⅳ型登革病毒ns1抗原的免疫诊断试剂盒 | |
CN109112114A (zh) | 抗人IgG单克隆抗体、其杂交瘤细胞株及应用 | |
CN109082413A (zh) | 抗人IgG单克隆抗体、其杂交瘤细胞株及应用 | |
CN108624564A (zh) | 抗乙肝表面抗原的单抗隆抗体的制备和筛选 | |
CN107267465A (zh) | 一株降钙素原单克隆抗体杂交瘤细胞株cs12‑1及其应用 | |
CN101921337B (zh) | 间日疟原虫乳酸脱氢酶抗体、相关制备方法、杂交瘤细胞株和应用 | |
CN105567643B (zh) | 可分泌抗ev71病毒蛋白vp1单克隆抗体的杂交瘤细胞、单克隆抗体及应用 | |
CN109280644A (zh) | 抗人IgG单克隆抗体、其杂交瘤细胞株及应用 | |
CN106526179B (zh) | 一种pvy单重病毒胶体金快速检测试纸条 | |
CN108588031A (zh) | 抗人IgM单克隆抗体、其杂交瘤细胞株及应用 | |
CN107058240A (zh) | 一株杂交瘤细胞株ab1及其产生的2,4,5‑三氯苯氧乙酸单克隆抗体 | |
CN108624565A (zh) | 一种抗乙肝表面抗原的单抗隆抗体制备和筛选 | |
CN105602906B (zh) | 可分泌抗突变b型肝炎病毒表面抗原单克隆抗体的杂交瘤细胞、单克隆抗体及应用 | |
CN106929479A (zh) | 一株维生素b2单克隆抗体杂交瘤细胞株gz‑4及其应用 | |
CN108148813A (zh) | 一株杂交瘤细胞株及其分泌的抗牛传染性鼻气管炎病毒单克隆抗体和应用 | |
CN107043752A (zh) | 杂交瘤细胞株及基于杂交瘤细胞株的抗crh抗体n‑d19及其检测方面的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: 518000 Guangdong city of Shenzhen province Nanshan District Xili liuxiandong Zhongshan Road No. 1001 TCL Science Park building D2 building 6 floor Applicant after: FAPON BIOTECH Inc. Address before: 518000 Guangdong city of Shenzhen province Nanshan District Xili liuxiandong Zhongshan Road No. 1001 TCL Science Park building D2 building 6 floor Applicant before: Shenzhen Feipeng Biological Co.,Ltd. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: SHENZHEN FAPON BIOTECH INC. TO: FAPON BIOTECH CORP. |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20170123 Address after: 518000 Guangdong city of Shenzhen province Nanshan District Xili liuxiandong Zhongshan Road No. 1001 TCL Science Park building D2 building 6 layer ABCD unit 601, 602, 603, 604. Applicant after: FAPON BIOTECH Inc. Applicant after: GUANGDONG FAPON BIOTECH Co.,Ltd. Address before: 518000 Guangdong city of Shenzhen province Nanshan District Xili liuxiandong Zhongshan Road No. 1001 TCL Science Park building D2 building 6 floor Applicant before: FAPON BIOTECH Inc. |
|
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Tian Inventor after: Tan Jun Inventor after: Wang Yiqiong Inventor after: Song Tao Inventor before: Yang Gengzhou Inventor before: Liu Derong Inventor before: Zhu Biyin Inventor before: Gong Chunxi Inventor before: Huo Yongting Inventor before: Feng Qiong Inventor before: Li Keguo Inventor before: Fan Lingyun Inventor before: Peng Liang Inventor before: Han Ricai |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20171116 Address after: 523000 Dongguan, Guangdong Province, Dongguan City, high and New Technology Industrial Development Zone, 1 holding building, room 8 building, room 811 Applicant after: Dongguan Biotechnology Industry Development Co.,Ltd. Address before: 518000 Guangdong city of Shenzhen province Nanshan District Xili liuxiandong Zhongshan Road No. 1001 TCL Science Park building D2 building 6 layer ABCD unit 601, 602, 603, 604. Applicant before: FAPON BIOTECH Inc. Applicant before: GUANGDONG FAPON BIOTECH Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180104 Address after: 518000 Guangdong city of Shenzhen province Nanshan District Xili liuxiandong Zhongshan Road No. 1001 TCL Science Park building D2 building 6 layer ABCD unit 601, 602, 603, 604. Co-patentee after: GUANGDONG FAPON BIOTECH Co.,Ltd. Patentee after: FAPON BIOTECH Inc. Address before: 523000 Dongguan, Guangdong Province, Dongguan City, high and New Technology Industrial Development Zone, 1 holding building, room 8 building, room 811 Patentee before: Dongguan Biotechnology Industry Development Co.,Ltd. |